| |
Categories
| |
|---|
|
Scores
| |
A – (N)=162
|
B – (N)=434
|
C – (N)=208
|
D – (N)=303
|
E – (N)=72
|
Overall – (N) = 1182
|
|---|
|
PANSS Total
|
|
Baseline
| |
45.56 (9.22)
|
55.29 (11.19)
|
64.91 (12.80)
|
71.50 (10.74)
|
93.63 (14.64)
|
61.53 (16.12)
|
|
6 months
| |
−4.39 (8.95)
|
−6.41 (11.09)
|
−10.80(12.98)
|
−9.73 (12.56)
|
−24.90(21.70)
|
−8.77 (13.14)
|
|
12 months
| |
−3.79 (11.55)
|
−6.32 (12.14)
|
−12.94(12.78)
|
−12.63(13.11)
|
−30.39(20.72)
|
−9.75 (14.29)
|
|
QLS Interpersonal
|
|
Baseline
| |
3.75 (1.03)
|
2.48 (1.00)
|
3.56 (1.02)
|
2.22 (1.03)
|
2.00 (0.98)
|
2.77 (1.19)
|
|
6 months
| |
0.02 (0.85)
|
0.38 (0.91)
|
0.11 (0.87)
|
0.41 (0.80)
|
0.42 (0.85)
|
0.28 (0.88)
|
|
12 months
| |
0.20 (0.89)
|
0.47 (0.99)
|
0.03 (0.92)
|
0.46 (0.82)
|
0.61 (0.83)
|
0.34 (0.93)
|
|
QLS Instrumental
|
|
Baseline
| |
4.26 (0.73)
|
1.75 (0.97)
|
4.11 (0.64)
|
1.50 (0.94)
|
1.27 (0.99)
|
2.53 (1.49)
|
|
6 months
| |
−0.34 (1.13)
|
0.52 (1.16)
|
−0.10 (0.97)
|
0.51 (1.13)
|
0.43 (1.07)
|
0.26 (1.16)
|
|
12 months
| |
−0.19 (1.04)
|
0.70 (1.27)
|
−0.10 (1.02)
|
0.68 (1.25)
|
1.05 (1.19)
|
−0.41 (1.25)
|
|
Remission – based on observed cases
|
|
n (%)
| |
A
|
B
|
C
|
D
|
E
|
Overall
|
|
Baseline - cross-sectional
| |
137 (84.6)
|
266 (61.3)
|
119 (57.2)
|
87 (28.7)
|
1 (1.4)
|
610 (51.6)
|
|
6 months - cross-sectional
| |
114 (95.8)
|
235 (80.2)
|
125 (81.2)
|
104 (59.1)
|
15 (33.3)
|
594 (75.5)
|
|
6 months - sustained
| |
99 (83.2)
|
159 (54.3)
|
90 (58.4)
|
46 (26.1)
|
1 (2.2)
|
395 (50.2)
|
|
12 months - cross-sectional
| |
106 (93.8)
|
204 (81.9)
|
101 (82.8)
|
95 (67.9)
|
15 (42.9)
|
521 (79.1)
|
|
12 months - sustained
| |
104 (92.0)
|
191 (76.7)
|
95 (77.9)
|
76 (54.3)
|
10 (28.6)
|
476 (72.2)
|
-
PANSS: Positive and Negative Symptoms Score, QLS: Heinrich Carpenter’s Quality of Life Scale, SD: standard deviation.
